Skip to content

A Comparison of Technegas and Xenon-133 Planar Lung Imaging in Subjects Referred for Ventilation Scintigraphy

A Comparison of Technegas® and Xenon 133 Planar Lung Imaging in Subjects Referred for Ventilation Scintigraphy

Status
Terminated
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03054870
Enrollment
226
Registered
2017-02-16
Start date
2017-09-01
Completion date
2020-11-23
Last updated
2021-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Structure Determination

Keywords

pulmonary ventilation, ventilation scintigraphy

Brief summary

Phase 3 within-subject non-inferiority trial of Technegas ventilation imaging compared to Xenon-133 (Xe-133) ventilation imaging to demonstrate the non-inferiority of Technegas compared to Xe-133 ventilation studies with respect to subject pulmonary ventilatory distribution. Subjects will undergo site-specific standard of care (SOC) Xe-133 imaging per medical needs followed by Technegas ventilation imaging per study protocol.

Detailed description

This is a Phase 3 within-subject non-inferiority trial of Technegas ventilation imaging compared to Xenon-133 (Xe-133) ventilation imaging to demonstrate the non-inferiority of Technegas compared to Xe-133 ventilation studies with respect to subject pulmonary ventilatory distribution. Subjects will undergo site-specific standard of care (SOC) Xe-133 imaging per medical needs followed by Technegas ventilation imaging per study protocol. Primary assessments of efficacy will be based on three blinded readers' assessments of the Technegas and Xe-133 ventilation images in independent reading sessions.

Interventions

DRUGXe-133

Xe-133 ventilation scintigraphy

DRUGTechnegas

Technegas ventilation scintigraphy

Sponsors

Cyclomedica Australia PTY Limited
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
NONE

Masking description

Independent blinded readers will assess all ventilation scintigraphy images, masked as to subject identity and re-identified with a unique random code number (different code numbers for Xe-133 and Technegas images). The Xe-133 and Technegas images will be read in separate reading sessions in random order.

Intervention model description

Subjects will undergo standard of care Xe-133 ventilation scintigraphy per medical needs followed by investigational Technegas ventilation scintigraphy per protocol.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or female subject at least 18 years of age. * Subject is a candidate for ventilation imaging. * Subject must be willing and able to provide informed consent. * Subject must be stable and able to undergo Xe-133 planar imaging and Technegas planar imaging. * Subject must be willing and agree to complete study procedures. * Subject is using adequate birth control, if female and fertile. Adequate birth control is defined as surgical sterilization, hormone contraceptive use or intrauterine device (IUD). * Female subject of child-bearing potential has a negative urine or serum pregnancy test. * Subject has had or is scheduled to have a chest X-ray within 24 hours prior to the investigational imaging study.

Exclusion criteria

* Subject has been administered any other radiopharmaceutical within a timeframe that might cause interference with study imaging. * Subject is a pregnant or lactating female. * Subject has received Technegas in the past. * Subject has received an investigational drug within 30 days prior to dosing. * Subject is hemodynamically unstable.

Design outcomes

Primary

MeasureTime frameDescription
Blinded Readers Percent Agreement (PA) for Matching Image ViewsThe median duration of Technegas imaging was 22 minutes. Blinded reader assessments of images ranged from <1 month to 16 months following the imaging (median 5 months).Three blinded readers independently assessed the Xe-133 and Technegas images in separate reading sessions. Readers were blinded to all clinical information except a subject's screening chest X-ray. Xe-133 images were obtained per site-specific standard of care. Technegas images included a 6-view image set, and the primary endpoint was based on assessment of the subset of views that matched the Xe-133 image views. At the start of each case-read, a reader visually divided each lung into 3 regions of approximately equal size arranged craniocaudally (apical, mid, and basal), 6 regions in total, and then assessed each lung region for ventilation according to a three-point scale: 0=absent ventilation, 1=decreased ventilation, 2=normal ventilation. At the unplanned interim stage, PA between the Xe-133 scores and Technegas scores was tested for non-inferiority at one-sided alpha=0.0141, equivalent to the lower bound of the 97.18% confidence interval exceeding 60%.

Secondary

MeasureTime frameDescription
Blinded Readers Percent Agreement (PA) for All Image ViewsThe median duration of Technegas imaging was 22 minutes. Blinded reader assessments of images ranged from <1 month to 16 months following the imaging (median 5 months).Three blinded readers independently assessed the Xe-133 and Technegas images in separate reading sessions. Readers were blinded to all clinical information except a subject's screening chest X-ray. Xe-133 images were obtained per site-specific standard of care. Technegas images included a 6-view image set. Two sequential reads were conducted of each subject's Technegas images. In the first read, only views that matched the Xe-133 image views were presented and read, and assessments based on the matched views were used in the primary outcome measure. Immediately following the commitment of those assessments, all Technegas image views were presented to the reader, and a second assessment of all the Technegas image views was made using the same ventilation scoring metric as described for the primary outcome measure. The estimation of PA and its analyses were also the same as for the primary outcome measure.
Percent Agreement Measuring Inter-observer AgreementThe median duration of Technegas imaging was 22 minutes. Blinded reader assessments of images ranged from <1 month to 16 months following the imaging (median 5 months).Percent agreement (PA) measuring inter-observer agreement between pairs of blinded readers for their ventilation scoring assessments within each of the three imaging groups: Xe-133, Technegas matched views, and Technegas all views. For each image set, a reader scored 6 regions of the lungs according to a three-point scale: 0=absent ventilation, 1=decreased ventilation, 2=normal ventilation; agreement between a pair of readers' assessments was based on the agreement of their ventilation scores by subject and lung region.
Kappa Statistics Between Pairs of Blinded Readers by Lung RegionThe median duration of Technegas imaging was 22 minutes. Blinded reader assessments of images ranged from <1 month to 16 months following the imaging (median 5 months).By lung-region kappa statistics measuring inter-observer agreement between pairs of blinded readers for their ventilation scoring assessments within each of the three imaging groups: Xe-133, Technegas matched views, and Technegas all views. For each image set, a reader scored 6 regions of the lungs according to a three-point scale: 0=absent ventilation, 1=decreased ventilation, 2=normal ventilation. Kappa statistics for a pair of readers' assessments were derived from the frequencies of the cross-tabulation of the readers' ventilation scores by lung region. Kappa statistics are an index of inter-observer agreement corrected for chance with possible values ranging from -1 to 1, where 1 represents perfect agreement.

Countries

United States

Participant flow

Participants by arm

ArmCount
Xe-133 Followed by Technegas
Subjects received the active comparator Xe-133 followed by inhalation of experimental Technegas on the same day.
210
Total210

Withdrawals & dropouts

PeriodReasonFG000
Day of Ventilation ImagingLost to Follow-up1
Day of Ventilation ImagingProtocol Violation4

Baseline characteristics

CharacteristicXe-133 Followed by Technegas
Age, Continuous60.4 years
STANDARD_DEVIATION 13.93
Body Mass Index29.14 kilogram/meter squared
STANDARD_DEVIATION 7.472
Ethnicity (NIH/OMB)
Hispanic or Latino
5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
205 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Pleural Effusion Observed in Screening Chest X-Ray
No
198 Participants
Pleural Effusion Observed in Screening Chest X-Ray
Yes
12 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
1 Participants
Race (NIH/OMB)
Black or African American
22 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
186 Participants
Reason for Ventilation Imaging
Chronic Obstructive Pulmonary Disease (COPD)
No
175 Participants
Reason for Ventilation Imaging
Chronic Obstructive Pulmonary Disease (COPD)
Yes
35 Participants
Reason for Ventilation Imaging
Other Reason
No
173 Participants
Reason for Ventilation Imaging
Other Reason
Yes
37 Participants
Reason for Ventilation Imaging
Pre or Post Lung Surgery Evaluation (Lung Transplant or Reduction)
No
113 Participants
Reason for Ventilation Imaging
Pre or Post Lung Surgery Evaluation (Lung Transplant or Reduction)
Yes
97 Participants
Reason for Ventilation Imaging
Pulmonary Hypertension
No
185 Participants
Reason for Ventilation Imaging
Pulmonary Hypertension
Yes
25 Participants
Reason for Ventilation Imaging
Pulmonary or Cystic Fibrosis
No
179 Participants
Reason for Ventilation Imaging
Pulmonary or Cystic Fibrosis
Yes
31 Participants
Reason for Ventilation Imaging
Suspected Pulmonary Embolism (PE) or Follow-up for PE
No
139 Participants
Reason for Ventilation Imaging
Suspected Pulmonary Embolism (PE) or Follow-up for PE
Yes
71 Participants
Screening Chest X-Ray
Interpretation Abnormal
143 Participants
Screening Chest X-Ray
Interpretation Normal
67 Participants
Sex: Female, Male
Female
99 Participants
Sex: Female, Male
Male
111 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 210
other
Total, other adverse events
7 / 210
serious
Total, serious adverse events
0 / 210

Outcome results

Primary

Blinded Readers Percent Agreement (PA) for Matching Image Views

Three blinded readers independently assessed the Xe-133 and Technegas images in separate reading sessions. Readers were blinded to all clinical information except a subject's screening chest X-ray. Xe-133 images were obtained per site-specific standard of care. Technegas images included a 6-view image set, and the primary endpoint was based on assessment of the subset of views that matched the Xe-133 image views. At the start of each case-read, a reader visually divided each lung into 3 regions of approximately equal size arranged craniocaudally (apical, mid, and basal), 6 regions in total, and then assessed each lung region for ventilation according to a three-point scale: 0=absent ventilation, 1=decreased ventilation, 2=normal ventilation. At the unplanned interim stage, PA between the Xe-133 scores and Technegas scores was tested for non-inferiority at one-sided alpha=0.0141, equivalent to the lower bound of the 97.18% confidence interval exceeding 60%.

Time frame: The median duration of Technegas imaging was 22 minutes. Blinded reader assessments of images ranged from <1 month to 16 months following the imaging (median 5 months).

Population: Full Analysis Set (FAS) consisting of subjects who completed all of the ventilation imaging on the study, and both sets of Xe-133 planar scans and the Technegas planar scans were of interpretable image quality according to site Investigators' assessment.

ArmMeasureValue (NUMBER)
Blinded Reader 03Blinded Readers Percent Agreement (PA) for Matching Image Views76.2 percentage of lung regions
Blinded Reader 04Blinded Readers Percent Agreement (PA) for Matching Image Views70.7 percentage of lung regions
Blinded Reader 05Blinded Readers Percent Agreement (PA) for Matching Image Views80.1 percentage of lung regions
Comparison: PA between Technegas and Xe-133 from analysis of each of the 3 blinded readers' ventilation scores was subjected to the following test of null (H0) versus alternate hypotheses (HA): H0: PA \<= 60% versus HA: PA \> 60%. The original sample size of 240 subjects was based on 90% power and one-sided alpha=0.025. For the unplanned interim analysis of 200 subjects, testing for non-inferiority used one-sided alpha=0.0141 (critical value provided by lower bound of the 97.18% confidence interval).p-value: <0.0141Mixed Models Analysis
Secondary

Blinded Readers Percent Agreement (PA) for All Image Views

Three blinded readers independently assessed the Xe-133 and Technegas images in separate reading sessions. Readers were blinded to all clinical information except a subject's screening chest X-ray. Xe-133 images were obtained per site-specific standard of care. Technegas images included a 6-view image set. Two sequential reads were conducted of each subject's Technegas images. In the first read, only views that matched the Xe-133 image views were presented and read, and assessments based on the matched views were used in the primary outcome measure. Immediately following the commitment of those assessments, all Technegas image views were presented to the reader, and a second assessment of all the Technegas image views was made using the same ventilation scoring metric as described for the primary outcome measure. The estimation of PA and its analyses were also the same as for the primary outcome measure.

Time frame: The median duration of Technegas imaging was 22 minutes. Blinded reader assessments of images ranged from <1 month to 16 months following the imaging (median 5 months).

Population: Full Analysis Set (FAS) consisting of subjects who completed all of the ventilation imaging on the study, and both sets of Xe-133 planar scans and the Technegas planar scans were of interpretable image quality according to site Investigators' assessment.

ArmMeasureValue (NUMBER)
Blinded Reader 03Blinded Readers Percent Agreement (PA) for All Image Views75.7 percentage of lung regions
Blinded Reader 04Blinded Readers Percent Agreement (PA) for All Image Views69.1 percentage of lung regions
Blinded Reader 05Blinded Readers Percent Agreement (PA) for All Image Views79.6 percentage of lung regions
Comparison: PA between Technegas and Xe-133 from analysis of each of the 3 blinded readers' ventilation scores was subjected to the following test of null (H0) versus alternate hypotheses (HA): H0: PA \<= 60% versus HA: PA \> 60%. The original sample size of 240 subjects was based on 90% power and one-sided alpha=0.025. For the unplanned interim analysis of 200 subjects, testing for non-inferiority used one-sided alpha=0.0141 (critical value provided by lower bound of the 97.18% confidence interval).p-value: <0.0141Mixed Models Analysis
Secondary

Kappa Statistics Between Pairs of Blinded Readers by Lung Region

By lung-region kappa statistics measuring inter-observer agreement between pairs of blinded readers for their ventilation scoring assessments within each of the three imaging groups: Xe-133, Technegas matched views, and Technegas all views. For each image set, a reader scored 6 regions of the lungs according to a three-point scale: 0=absent ventilation, 1=decreased ventilation, 2=normal ventilation. Kappa statistics for a pair of readers' assessments were derived from the frequencies of the cross-tabulation of the readers' ventilation scores by lung region. Kappa statistics are an index of inter-observer agreement corrected for chance with possible values ranging from -1 to 1, where 1 represents perfect agreement.

Time frame: The median duration of Technegas imaging was 22 minutes. Blinded reader assessments of images ranged from <1 month to 16 months following the imaging (median 5 months).

Population: Full Analysis Set (FAS)

ArmMeasureGroupValue (NUMBER)
Blinded Reader 03Kappa Statistics Between Pairs of Blinded Readers by Lung RegionRight Lung Apical: Pair 03, 040.665 Index of inter-reader agreement
Blinded Reader 03Kappa Statistics Between Pairs of Blinded Readers by Lung RegionLeft Lung Apical: Pair 03, 050.500 Index of inter-reader agreement
Blinded Reader 03Kappa Statistics Between Pairs of Blinded Readers by Lung RegionLeft Lung Mid: Pair 04, 050.527 Index of inter-reader agreement
Blinded Reader 03Kappa Statistics Between Pairs of Blinded Readers by Lung RegionLeft Lung Apical: Pair 03, 040.479 Index of inter-reader agreement
Blinded Reader 03Kappa Statistics Between Pairs of Blinded Readers by Lung RegionRight Lung Mid: 03, 050.478 Index of inter-reader agreement
Blinded Reader 03Kappa Statistics Between Pairs of Blinded Readers by Lung RegionLeft Lung Mid: Pair 03, 040.551 Index of inter-reader agreement
Blinded Reader 03Kappa Statistics Between Pairs of Blinded Readers by Lung RegionRight Lung Basal: 03, 040.486 Index of inter-reader agreement
Blinded Reader 03Kappa Statistics Between Pairs of Blinded Readers by Lung RegionLeft Lung Mid: Pair 03, 050.538 Index of inter-reader agreement
Blinded Reader 03Kappa Statistics Between Pairs of Blinded Readers by Lung RegionRight Lung Basal: 03, 050.479 Index of inter-reader agreement
Blinded Reader 03Kappa Statistics Between Pairs of Blinded Readers by Lung RegionLeft Lung Basal: Pair 03, 040.530 Index of inter-reader agreement
Blinded Reader 03Kappa Statistics Between Pairs of Blinded Readers by Lung RegionRight Lung Basal: 04, 050.519 Index of inter-reader agreement
Blinded Reader 03Kappa Statistics Between Pairs of Blinded Readers by Lung RegionRight Lung Mid: 03, 040.583 Index of inter-reader agreement
Blinded Reader 03Kappa Statistics Between Pairs of Blinded Readers by Lung RegionLeft Lung Basal: Pair 03, 050.517 Index of inter-reader agreement
Blinded Reader 03Kappa Statistics Between Pairs of Blinded Readers by Lung RegionRight Lung Mid: 04, 050.511 Index of inter-reader agreement
Blinded Reader 03Kappa Statistics Between Pairs of Blinded Readers by Lung RegionRight Lung Apical: Pair 04, 050.581 Index of inter-reader agreement
Blinded Reader 03Kappa Statistics Between Pairs of Blinded Readers by Lung RegionLeft Lung Basal: Pair 04, 050.469 Index of inter-reader agreement
Blinded Reader 03Kappa Statistics Between Pairs of Blinded Readers by Lung RegionLeft Lung Apical: Pair 04, 050.538 Index of inter-reader agreement
Blinded Reader 03Kappa Statistics Between Pairs of Blinded Readers by Lung RegionRight Lung Apical: Pair 03, 050.589 Index of inter-reader agreement
Blinded Reader 04Kappa Statistics Between Pairs of Blinded Readers by Lung RegionLeft Lung Apical: Pair 04, 050.481 Index of inter-reader agreement
Blinded Reader 04Kappa Statistics Between Pairs of Blinded Readers by Lung RegionLeft Lung Apical: Pair 03, 040.529 Index of inter-reader agreement
Blinded Reader 04Kappa Statistics Between Pairs of Blinded Readers by Lung RegionLeft Lung Apical: Pair 03, 050.558 Index of inter-reader agreement
Blinded Reader 04Kappa Statistics Between Pairs of Blinded Readers by Lung RegionLeft Lung Mid: Pair 03, 040.474 Index of inter-reader agreement
Blinded Reader 04Kappa Statistics Between Pairs of Blinded Readers by Lung RegionLeft Lung Basal: Pair 03, 040.466 Index of inter-reader agreement
Blinded Reader 04Kappa Statistics Between Pairs of Blinded Readers by Lung RegionLeft Lung Basal: Pair 03, 050.553 Index of inter-reader agreement
Blinded Reader 04Kappa Statistics Between Pairs of Blinded Readers by Lung RegionLeft Lung Basal: Pair 04, 050.424 Index of inter-reader agreement
Blinded Reader 04Kappa Statistics Between Pairs of Blinded Readers by Lung RegionRight Lung Apical: Pair 03, 040.484 Index of inter-reader agreement
Blinded Reader 04Kappa Statistics Between Pairs of Blinded Readers by Lung RegionRight Lung Mid: 04, 050.530 Index of inter-reader agreement
Blinded Reader 04Kappa Statistics Between Pairs of Blinded Readers by Lung RegionRight Lung Basal: 03, 050.530 Index of inter-reader agreement
Blinded Reader 04Kappa Statistics Between Pairs of Blinded Readers by Lung RegionLeft Lung Mid: Pair 03, 050.560 Index of inter-reader agreement
Blinded Reader 04Kappa Statistics Between Pairs of Blinded Readers by Lung RegionLeft Lung Mid: Pair 04, 050.434 Index of inter-reader agreement
Blinded Reader 04Kappa Statistics Between Pairs of Blinded Readers by Lung RegionRight Lung Apical: Pair 03, 050.621 Index of inter-reader agreement
Blinded Reader 04Kappa Statistics Between Pairs of Blinded Readers by Lung RegionRight Lung Apical: Pair 04, 050.593 Index of inter-reader agreement
Blinded Reader 04Kappa Statistics Between Pairs of Blinded Readers by Lung RegionRight Lung Mid: 03, 040.518 Index of inter-reader agreement
Blinded Reader 04Kappa Statistics Between Pairs of Blinded Readers by Lung RegionRight Lung Mid: 03, 050.663 Index of inter-reader agreement
Blinded Reader 04Kappa Statistics Between Pairs of Blinded Readers by Lung RegionRight Lung Basal: 03, 040.448 Index of inter-reader agreement
Blinded Reader 04Kappa Statistics Between Pairs of Blinded Readers by Lung RegionRight Lung Basal: 04, 050.496 Index of inter-reader agreement
Blinded Reader 05Kappa Statistics Between Pairs of Blinded Readers by Lung RegionRight Lung Apical: Pair 03, 040.495 Index of inter-reader agreement
Blinded Reader 05Kappa Statistics Between Pairs of Blinded Readers by Lung RegionRight Lung Mid: 03, 040.464 Index of inter-reader agreement
Blinded Reader 05Kappa Statistics Between Pairs of Blinded Readers by Lung RegionLeft Lung Mid: Pair 04, 050.421 Index of inter-reader agreement
Blinded Reader 05Kappa Statistics Between Pairs of Blinded Readers by Lung RegionLeft Lung Basal: Pair 04, 050.461 Index of inter-reader agreement
Blinded Reader 05Kappa Statistics Between Pairs of Blinded Readers by Lung RegionLeft Lung Mid: Pair 03, 040.509 Index of inter-reader agreement
Blinded Reader 05Kappa Statistics Between Pairs of Blinded Readers by Lung RegionRight Lung Apical: Pair 03, 050.596 Index of inter-reader agreement
Blinded Reader 05Kappa Statistics Between Pairs of Blinded Readers by Lung RegionLeft Lung Basal: Pair 03, 050.510 Index of inter-reader agreement
Blinded Reader 05Kappa Statistics Between Pairs of Blinded Readers by Lung RegionLeft Lung Apical: Pair 03, 040.503 Index of inter-reader agreement
Blinded Reader 05Kappa Statistics Between Pairs of Blinded Readers by Lung RegionRight Lung Apical: Pair 04, 050.559 Index of inter-reader agreement
Blinded Reader 05Kappa Statistics Between Pairs of Blinded Readers by Lung RegionLeft Lung Basal: Pair 03, 040.452 Index of inter-reader agreement
Blinded Reader 05Kappa Statistics Between Pairs of Blinded Readers by Lung RegionRight Lung Basal: 03, 050.533 Index of inter-reader agreement
Blinded Reader 05Kappa Statistics Between Pairs of Blinded Readers by Lung RegionRight Lung Basal: 04, 050.509 Index of inter-reader agreement
Blinded Reader 05Kappa Statistics Between Pairs of Blinded Readers by Lung RegionRight Lung Basal: 03, 040.427 Index of inter-reader agreement
Blinded Reader 05Kappa Statistics Between Pairs of Blinded Readers by Lung RegionLeft Lung Apical: Pair 04, 050.467 Index of inter-reader agreement
Blinded Reader 05Kappa Statistics Between Pairs of Blinded Readers by Lung RegionRight Lung Mid: 04, 050.515 Index of inter-reader agreement
Blinded Reader 05Kappa Statistics Between Pairs of Blinded Readers by Lung RegionRight Lung Mid: 03, 050.682 Index of inter-reader agreement
Blinded Reader 05Kappa Statistics Between Pairs of Blinded Readers by Lung RegionLeft Lung Apical: Pair 03, 050.589 Index of inter-reader agreement
Blinded Reader 05Kappa Statistics Between Pairs of Blinded Readers by Lung RegionLeft Lung Mid: Pair 03, 050.571 Index of inter-reader agreement
Secondary

Percent Agreement Measuring Inter-observer Agreement

Percent agreement (PA) measuring inter-observer agreement between pairs of blinded readers for their ventilation scoring assessments within each of the three imaging groups: Xe-133, Technegas matched views, and Technegas all views. For each image set, a reader scored 6 regions of the lungs according to a three-point scale: 0=absent ventilation, 1=decreased ventilation, 2=normal ventilation; agreement between a pair of readers' assessments was based on the agreement of their ventilation scores by subject and lung region.

Time frame: The median duration of Technegas imaging was 22 minutes. Blinded reader assessments of images ranged from <1 month to 16 months following the imaging (median 5 months).

Population: Full Analysis Set (FAS)

ArmMeasureGroupValue (NUMBER)
Blinded Reader 03Percent Agreement Measuring Inter-observer AgreementReader Pair 03, 0580.4 percentage of lung regions
Blinded Reader 03Percent Agreement Measuring Inter-observer AgreementReader Pair 03, 0482.8 percentage of lung regions
Blinded Reader 03Percent Agreement Measuring Inter-observer AgreementReader Pair 04, 0579.6 percentage of lung regions
Blinded Reader 04Percent Agreement Measuring Inter-observer AgreementReader Pair 03, 0581.2 percentage of lung regions
Blinded Reader 04Percent Agreement Measuring Inter-observer AgreementReader Pair 03, 0472.7 percentage of lung regions
Blinded Reader 04Percent Agreement Measuring Inter-observer AgreementReader Pair 04, 0573.9 percentage of lung regions
Blinded Reader 05Percent Agreement Measuring Inter-observer AgreementReader Pair 03, 0471.6 percentage of lung regions
Blinded Reader 05Percent Agreement Measuring Inter-observer AgreementReader Pair 04, 0573.4 percentage of lung regions
Blinded Reader 05Percent Agreement Measuring Inter-observer AgreementReader Pair 03, 0580.8 percentage of lung regions

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026